Hiroaki Kitade

1.9k total citations
76 papers, 1.5k citations indexed

About

Hiroaki Kitade is a scholar working on Surgery, Immunology and Hepatology. According to data from OpenAlex, Hiroaki Kitade has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 19 papers in Immunology and 17 papers in Hepatology. Recurrent topics in Hiroaki Kitade's work include Immune Cell Function and Interaction (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hiroaki Kitade is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hiroaki Kitade collaborates with scholars based in Japan, Belgium and United States. Hiroaki Kitade's co-authors include A‐Hon Kwon, Yasuo Kamiyama, Masaki Kaibori, Jacques Pirenne, Mark Waer, Yoichi Matsui, Toshiki Kanemaki, Chantal Mathieu, Sohei Satoi and Tadayoshi Okumura and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Hepatology.

In The Last Decade

Hiroaki Kitade

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Kitade Japan 24 506 321 320 284 254 76 1.5k
G. J. Gores United States 20 520 1.0× 326 1.0× 394 1.2× 444 1.6× 118 0.5× 40 1.5k
Anna Planagumà Spain 16 211 0.4× 352 1.1× 224 0.7× 275 1.0× 258 1.0× 23 1.3k
Shelley Kopriva United States 18 340 0.7× 159 0.5× 238 0.7× 254 0.9× 74 0.3× 25 1.3k
Chengwei Tang China 26 883 1.7× 665 2.1× 377 1.2× 617 2.2× 119 0.5× 161 2.2k
Rebecca Schuster United States 29 526 1.0× 486 1.5× 447 1.4× 1.1k 3.8× 162 0.6× 84 2.5k
Wei An China 27 629 1.2× 612 1.9× 336 1.1× 773 2.7× 146 0.6× 96 2.1k
Jianbin Bi China 20 240 0.5× 322 1.0× 114 0.4× 593 2.1× 406 1.6× 45 1.4k
Kengo Tomita Japan 23 327 0.6× 691 2.2× 264 0.8× 425 1.5× 194 0.8× 57 1.5k
Haibo Zhang China 13 143 0.3× 644 2.0× 240 0.8× 350 1.2× 188 0.7× 30 1.4k
Javier Pereda Spain 24 693 1.4× 299 0.9× 68 0.2× 345 1.2× 227 0.9× 40 1.6k

Countries citing papers authored by Hiroaki Kitade

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kitade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kitade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kitade more than expected).

Fields of papers citing papers by Hiroaki Kitade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kitade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kitade. The network helps show where Hiroaki Kitade may publish in the future.

Co-authorship network of co-authors of Hiroaki Kitade

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kitade. A scholar is included among the top collaborators of Hiroaki Kitade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kitade. Hiroaki Kitade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakatake, Richi, Tetsuya Okuyama, Yuki Hashimoto, et al.. (2024). Sulforaphane Is Protective against Warm Ischemia/Reperfusion Injury and Partial Hepatectomy in Rats. International Journal of Molecular Sciences. 25(1). 579–579. 2 indexed citations
2.
Okuyama, Tetsuya, Yuki Hashimoto, Hiroaki Kitade, et al.. (2024). Olprinone, a Selective Phosphodiesterase III Inhibitor, Has Protective Effects in a Septic Rat Model after Partial Hepatectomy and Primary Rat Hepatocyte. International Journal of Molecular Sciences. 25(13). 7189–7189.
3.
Nakatake, Richi, Hiroaki Kitade, Morihiko Ishizaki, et al.. (2024). Giant hemorrhagic pancreatic pseudocyst with suspected cystic pancreatic tumor: a case report. Journal of Surgical Case Reports. 2024(6). rjae393–rjae393.
4.
Nakatake, Richi, Tetsuya Okuyama, Morihiko Ishizaki, et al.. (2024). Hepatoprotection of a Standardized Extract of Cultured Lentinula edodes Mycelia against Liver Injury Induced by Ischemia-Reperfusion and Partial Hepatectomy. Nutrients. 16(2). 256–256. 1 indexed citations
5.
Kitade, Hiroaki, Hidesuke Yanagida, Masanori Yamada, et al.. (2015). Granulocyte-colony stimulating factor producing anaplastic carcinoma of the pancreas treated by distal pancreatectomy and chemotherapy: report of a case. Surgical Case Reports. 1(1). 46–46. 24 indexed citations
7.
Hamazaki, Kei, Hiroaki Kitade, Takashi Matsuura, et al.. (2013). Abnormalities in fatty acids in plasma, erythrocytes and adipose tissue in Japanese patients with colorectal cancer.. PubMed. 27(2). 203–10. 27 indexed citations
8.
Satoi, Sohei, Hideyoshi Toyokawa, Hiroaki Yanagimoto, et al.. (2011). Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer. Journal of Gastrointestinal Surgery. 16(4). 784–792. 31 indexed citations
9.
Satoi, Sohei, Hiroaki Yanagimoto, Hideyoshi Toyokawa, et al.. (2009). Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Suizo. 24(5). 630–631. 2 indexed citations
10.
Kitade, Hiroaki, et al.. (2009). Intestinal Ischemia Reperfusion and Lipopolysaccharide Transform a Tolerogenic Signal into a Sensitizing Signal and Trigger Rejection. Transplantation. 87(10). 1464–1467. 16 indexed citations
11.
Kaibori, Masaki, Kosuke Matsui, Morihiko Ishizaki, et al.. (2009). Hepatic resection for hepatocellular carcinoma in the elderly. Journal of Surgical Oncology. 99(3). 154–160. 62 indexed citations
12.
Pirenne, Jacques, Kanji Takahashi, Hiroaki Kitade, et al.. (2007). Translation into the clinic of an experimentally proven pro-regulatory immunomodulatory protocol for intestinal transplantation. Long-term results. Transplant International. 20. 17–17. 1 indexed citations
13.
Kwon, A‐Hon, et al.. (2007). FDG-PET USEFUL FOR DETECTING A CASE OF PERITONEAL MALIGNANT MESOTHELIOMA. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68(9). 2367–2371. 5 indexed citations
14.
Yamada, M., et al.. (2006). [Three cases of drug-induced akathisia due to antiemetics during cancer palliative care].. PubMed. 33(2). 267–9. 4 indexed citations
15.
Kawai, Makiko, Hiroaki Kitade, Chantal Mathieu, Mark Waer, & Jacques Pirenne. (2006). Differential effect of immunosuppressive drugs on the development of regulatory cells. American Journal of Transplantation. 313–313. 1 indexed citations
16.
Kitade, Hiroaki, Omer Rutgeerts, Willy Landuyt, et al.. (2005). Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion. The Journal of Immunology. 175(8). 4963–4970. 30 indexed citations
17.
Koshiba, T, Hiroaki Kitade, Boudewijn Van Damme, et al.. (2003). Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation. 76(3). 588–596. 33 indexed citations
18.
Kitade, Hiroaki, Mark Waer, Karel Geboes, et al.. (2002). Complete freedom from rejection, infection and drug toxicity after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation. 74. 1 indexed citations
19.
Uchida, Yoichiro, et al.. (2001). Our Experience with the Groshong Catheter. 53(2-4). 141–147.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026